Donor transplant therapy allogeneic stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy30

Stem Cells Antilymphocyte Serum Hematopoietic Stem Cells T-Lymphocytes Embryonic Stem Cells Adult Stem Cells Bone Marrow Cells Pluripotent Stem Cells CD8-Positive T-Lymphocytes Neural Stem Cells Mesenchymal Stromal Cells Cells, Cultured Bone Marrow Transplants T-Lymphocytes, Cytotoxic Induced Pluripotent Stem Cells Multipotent Stem Cells Philadelphia Chromosome CD4-Positive T-Lymphocytes Fetal Blood Fetal Stem Cells Lymphocytes Killer Cells, Natural T-Lymphocyte Subsets T-Lymphocytes, Regulatory Allografts Spermatogonia Blood Cells Neoplastic Stem Cells Dendritic Cells

Organisms9

Transplantation Chimera Cytomegalovirus Herpesvirus 6, Human Mice, Inbred C57BL Herpesvirus 4, Human Mice, Inbred BALB C Radiation Chimera Mice, SCID Chimera

Diseases50

Graft vs Host Disease Hematologic Neoplasms Recurrence Leukemia Leukemia, Myeloid, Acute Multiple Myeloma Cytomegalovirus Infections Leukemia, Myelogenous, Chronic, BCR-ABL Positive Myelodysplastic Syndromes Neoplasm, Residual Precursor Cell Lymphoblastic Leukemia-Lymphoma Hepatic Veno-Occlusive Disease Acute Disease Cadaver Anemia, Aplastic Primary Myelofibrosis Hematologic Diseases Leukemia, Myeloid, Accelerated Phase Lymphoproliferative Disorders Roseolovirus Infections Leukemia, Myeloid Hodgkin Disease Infection Opportunistic Infections Lymphoma, Non-Hodgkin Stomatitis Mycoses Adenoviridae Infections Epstein-Barr Virus Infections Leukemia, Lymphocytic, Chronic, B-Cell Chronic Disease Lymphoma Blast Crisis Lymphoma, Follicular Aspergillosis Viremia Philadelphia Chromosome Neoplasms Neoplasm Recurrence, Local Postoperative Complications Disease Progression Severe Combined Immunodeficiency Blood Group Incompatibility Liver Failure Lymphoma, Mantle-Cell Bronchiolitis Obliterans Disease Models, Animal Iron Overload Liver Diseases Amyloidosis

Chemicals and Drugs50

Myeloablative Agonists Busulfan Immunosuppressive Agents Vidarabine Antilymphocyte Serum Minor Histocompatibility Antigens Melphalan Cyclophosphamide HLA Antigens Antigens, CD34 Antibodies, Neoplasm Cytarabine Cyclosporine Benzamides Antineoplastic Agents Fusion Proteins, bcr-abl Ganciclovir Receptors, Purinergic P2X5 Pyrimidines Granulocyte Colony-Stimulating Factor Piperazines Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Etoposide Benzydamine Antiviral Agents Antigens, CD Vincristine Antibodies, Monoclonal, Humanized Tacrolimus Antigens, Viral DNA, Viral Viral Matrix Proteins Stem Cell Factor Isoantigens Carmustine fms-Like Tyrosine Kinase 3 Thiotepa Cytokines Biological Markers Antineoplastic Agents, Alkylating Thalidomide Antigens, Neoplasm Antifungal Agents HLA-A2 Antigen Interferon-gamma Mycophenolic Acid Prednisone Isoantibodies ABO Blood-Group System

Analytical, Diagnostic and Therapeutic Techniques and Equipment81

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Transplantation Conditioning Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Bone Marrow Transplantation Treatment Outcome Histocompatibility Testing Kidney Transplantation Remission Induction Retrospective Studies Whole-Body Irradiation Lymphocyte Transfusion Survival Rate Survival Analysis Cord Blood Stem Cell Transplantation Combined Modality Therapy Salvage Therapy Liver Transplantation Disease-Free Survival Lymphocyte Depletion Mesenchymal Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Cell Transplantation Immunosuppression Heart Transplantation Prognosis Lung Transplantation Risk Factors Fatal Outcome Transplantation Transplantation, Isogeneic Immunotherapy, Adoptive Leukocyte Transfusion Flow Cytometry Prospective Studies Lymphocyte Count Immunotherapy Actuarial Analysis Polymerase Chain Reaction Islets of Langerhans Transplantation Incidence Organ Transplantation Immunophenotyping Cytogenetic Analysis Cohort Studies Clinical Trials as Topic Kaplan-Meier Estimate Cell Separation Feasibility Studies Fetal Tissue Transplantation Multivariate Analysis Reverse Transcriptase Polymerase Chain Reaction Pancreas Transplantation Leukapheresis Viral Load Transplantation, Heterotopic Pilot Projects Skin Transplantation Lymphocyte Activation Transplantation, Heterologous Donor Selection Drug Evaluation Predictive Value of Tests Cell Culture Techniques Bone Marrow Purging Heart-Lung Transplantation Stem Cell Research Life Tables Lymphocyte Culture Test, Mixed Risk Assessment Cell- and Tissue-Based Therapy Disease Models, Animal Case-Control Studies Blood Component Removal Corneal Transplantation Platelet Transfusion Brain Tissue Transplantation

Psychiatry and Psychology2

Siblings Nuclear Family

Phenomena and Processes27

Graft Survival Graft vs Leukemia Effect Graft vs Tumor Effect Histocompatibility Time Factors Graft Rejection Virus Activation Chimerism Transplantation Immunology Immunocompromised Host Cell Differentiation Lymphocyte Count Stem Cell Niche T-Cell Antigen Receptor Specificity Cell Proliferation Transplantation Tolerance Hematopoiesis Philadelphia Chromosome Cell Lineage Cytotoxicity, Immunologic Viral Load Lymphocyte Activation Regeneration Drug Resistance, Neoplasm Graft vs Host Reaction Radiation Chimera Karyotype

Disciplines and Occupations2

Hematology Stem Cell Research

Anthropology, Education, Sociology and Social Phenomena2

Siblings Nuclear Family

Information Science4

Survival Rate Fatal Outcome Incidence Life Tables

Named Groups5

Tissue Donors Living Donors Siblings Unrelated Donors Blood Donors

Health Care26

Treatment Outcome Retrospective Studies Survival Rate Survival Analysis Disease-Free Survival Tissue and Organ Procurement Directed Tissue Donation Follow-Up Studies Risk Factors Fatal Outcome Waiting Lists Prospective Studies Actuarial Analysis Incidence Cohort Studies Clinical Trials as Topic Kaplan-Meier Estimate Feasibility Studies Multivariate Analysis Pilot Projects Donor Selection Predictive Value of Tests Life Tables Risk Assessment Case-Control Studies Age Factors

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Graft vs Host Disease Transplantation Conditioning Tissue Donors Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Hematologic Neoplasms Bone Marrow Transplantation Transplantation Chimera Stem Cells Graft Survival Treatment Outcome Histocompatibility Testing Graft vs Leukemia Effect Kidney Transplantation Myeloablative Agonists Busulfan Living Donors Immunosuppressive Agents Recurrence Remission Induction Vidarabine Graft vs Tumor Effect Histocompatibility Retrospective Studies Antilymphocyte Serum Whole-Body Irradiation Lymphocyte Transfusion Leukemia Leukemia, Myeloid, Acute Survival Rate Survival Analysis Multiple Myeloma Cytomegalovirus Infections Cord Blood Stem Cell Transplantation Siblings Leukemia, Myelogenous, Chronic, BCR-ABL Positive Combined Modality Therapy Hematopoietic Stem Cells Minor Histocompatibility Antigens Salvage Therapy Liver Transplantation Disease-Free Survival Time Factors Lymphocyte Depletion Graft Rejection Myelodysplastic Syndromes Virus Activation Neoplasm, Residual Tissue and Organ Procurement Precursor Cell Lymphoblastic Leukemia-Lymphoma Melphalan Chimerism Hepatic Veno-Occlusive Disease Directed Tissue Donation Cytomegalovirus Mesenchymal Stem Cell Transplantation Cyclophosphamide T-Lymphocytes Hematopoietic Stem Cell Mobilization Antineoplastic Combined Chemotherapy Protocols Acute Disease Cadaver Unrelated Donors HLA Antigens Follow-Up Studies Cell Transplantation Anemia, Aplastic Immunosuppression Primary Myelofibrosis Transplantation Immunology Heart Transplantation Hematologic Diseases Prognosis Embryonic Stem Cells Leukemia, Myeloid, Accelerated Phase Blood Donors Antigens, CD34 Immunocompromised Host Antibodies, Neoplasm Lymphoproliferative Disorders Roseolovirus Infections Cytarabine Cyclosporine Benzamides Adult Stem Cells Leukemia, Myeloid Lung Transplantation Antineoplastic Agents Fusion Proteins, bcr-abl Risk Factors Hodgkin Disease Ganciclovir Receptors, Purinergic P2X5 Pyrimidines Nuclear Family Infection Fatal Outcome

No FAQ available that match "donor transplant therapy allogeneic stem cell transplantation"